Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
The Arterial Revascularization Therapy Study (ARTS) and the Stent or Surgery (SoS) trial each randomized patients with multivessel disease to either stenting or bypass surgery. The ARTS showed no difference in mortality between the two strategies, other than in diabetic patients, who fared better wi...
Uloženo v:
| Vydáno v: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806809/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-6-260 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|